Literature DB >> 8856691

Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study.

P F Kennel1, F Finiels, F Revah, J Mallet.   

Abstract

Dominant mutations of human Cu/Zn superoxide dismutase (SOD1) are found in about 20% of patients with familial amyotrophic lateral sclerosis (FALS). A transgenic mouse model of FALS (FALSG93A mice) has been generated by overexpression of a mutated form of SOD1. Using electromyography we first show that FALSG93A mice suffer from motoneurone dysfunction similar to that observed in ALS patients and fulfill Lambert's criteria for ALS. We also showed that FALSG93A mice demonstrate a massive loss of functional motor units starting at 47 days of age. Impairment of motor neurone function preceeds by 6 weeks the onset of apparent clinical signs (shaking, tremor) and the beginning of motor neurone loss. Neuromuscular deficits in FALS mice do not result from motoneuronal cell death but rather from loss of axonal integrity.

Entities:  

Mesh:

Year:  1996        PMID: 8856691     DOI: 10.1097/00001756-199605310-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  52 in total

Review 1.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

2.  Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.

Authors:  Surendra K Ravula; Min S Wang; Maxine A McClain; Seneshaw A Asress; Bruno Frazier; Jonathan D Glass
Journal:  Neurosci Lett       Date:  2007-01-10       Impact factor: 3.046

3.  Electrophysiological characterization of neuromuscular synaptic dysfunction in mice.

Authors:  Yoshie Sugiura; Fujun Chen; Yun Liu; Weichun Lin
Journal:  Methods Mol Biol       Date:  2011

4.  Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease.

Authors:  Victoria N Jensen; Shannon H Romer; Sarah M Turner; Steven A Crone
Journal:  J Vis Exp       Date:  2017-04-17       Impact factor: 1.355

5.  Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.

Authors:  Emiliano Trias; Mariángeles Kovacs; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Ivan C Moura; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  Glia       Date:  2019-12-20       Impact factor: 7.452

Review 6.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

7.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04

8.  Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.

Authors:  Thomas S Guillot; Seneshaw A Asress; Jason R Richardson; Jonathan D Glass; Gary W Miller
Journal:  J Mot Behav       Date:  2008-11       Impact factor: 1.328

Review 9.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

10.  Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.

Authors:  C R Hayworth; F Gonzalez-Lima
Journal:  Neuroscience       Date:  2009-08-20       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.